Aims Mortality after cardiac resynchronization therapy (CRT) is difficult to predict. We sought
to design and validate a simple prognostic score for patients implanted with CRT, based on …

Aims The European CRT Survey is a joint initiative of the Heart Failure Association (HFA)
and the European Heart Rhythm Association (EHRA) of the European Society of Cardiology …

BACKGROUND: The influence of comorbid conditions on ventricular remodeling, functional
status, and clinical outcome after cardiac resynchronization therapy (CRT) is insufficiently …

Aims Cardiac resynchronization therapy (CRT) has been shown to improve symptoms and
exercise tolerance in patients with advanced heart failure (HF). However, studies were …

Background: Cardiac resynchronization therapy (CRT) improves symptoms, left ventricular
ejection fraction (LVEF) and survival in patients with heart failure and wide QRS, however …

Abstract Aims The European cardiac resynchronization therapy (CRT) survey is a joint
initiative taken by the Heart Failure Association and the European Heart Rhythm Association …

Aims We hypothesized that a very advanced stage of dilated cardiomyopathy is associated
with lower response to cardiac resynchronization therapy (CRT). Methods and results A …

Background Cardiac resynchronization therapy (CRT) is one of the most successful heart
failure therapies to emerge in the last 25 years and is applicable to∼ 25–30% of patients …

Aims Cardiac resynchronization therapy (CRT-P) is an effective treatment for patients with
heart failure and cardiac dyssynchrony with moderate or severe symptoms despite …

Background—Cardiac resynchronization therapy (CRT) alone or combined with an
implantable defibrillator (CRT-D) has been shown to improve exercise capacity and quality …